Literature DB >> 20371959

Refractory Evans syndrome after autologous stem cell transplantation for multiple myeloma: management with a second transplantation.

Dai Chihara1, Takashi Sakamoto, Kazue Arimoto-Miyamoto, Wataru Kishimoto, Tomoharu Takeoka, Masaaki Tsuji, Tatsuharu Ohno.   

Abstract

The development of autoimmune disease after autologous stem cell transplantation (ASCT) is very rare in multiple myeloma (MM). We describe the first case of Evans syndrome after ASCT for MM. A 60-year-old man with MM received ASCT and subsequently developed Evans syndrome following two febrile episodes. The syndrome was refractory to conventional therapies but it was managed with a second ASCT. This unique complication was thought to have been triggered by an infection during the recovery of the immune system. We assumed that reconstructing the immune system via ASCT might eliminate infection-induced autoantibodies to platelets and erythrocytes.

Entities:  

Mesh:

Year:  2010        PMID: 20371959     DOI: 10.2169/internalmedicine.49.2922

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  A Rare Case of Multiple Myeloma Presenting as Evan's Syndrome.

Authors:  Anthony Karapetians; Tushar Bajaj; Amanda Valdes; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 2.  Evans syndrome: clinical perspectives, biological insights and treatment modalities.

Authors:  José Carlos Jaime-Pérez; Patrizia Elva Aguilar-Calderón; Lorena Salazar-Cavazos; David Gómez-Almaguer
Journal:  J Blood Med       Date:  2018-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.